查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372802

腫瘤營養市場-全球產業規模、佔有率、趨勢、機會和預測，2018-2028年按癌症類型、營養、配方、配方、最終用戶、地區、競爭預測和機會細分，2018-2028F

Oncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Cancer Type, By Nutrition, By Formula, By Formula, By End User, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球腫瘤營養市場估值為 21.4 億美元，預計在預測期內將大幅成長，預計到 2028 年年複合成長率 (CAGR) 將達到令人印象深刻的 8.41%。這個全球市場屬於醫療保健行業致力於為癌症患者提供專業的營養產品和服務。癌症及其治療會深刻影響患者的營養需求和整體健康。腫瘤營養致力於透過提供客製化解決方案來應對這些挑戰，在患者的整個癌症治療過程中為患者提供幫助和支持。

主要市場促進因素

癌症發生率上升

市場概況
預測期 2024-2028
2022 年市場規模 21.4億美元
2028 年市場規模 34.5億美元
2023-2028 年年複合成長率 8.41%
成長最快的細分市場 腸內營養
最大的市場 北美洲

全球腫瘤營養市場的需求正在大幅成長，而這一成長背後的關鍵促進因素之一是全球癌症發病率的驚人成長。隨著癌症每年繼續影響更多的生命，對專門營養支持的需求從未如此強烈。癌症已達到流行病的程度，其發生率在全球範圍內穩步上升。根據世界癌症研究基金會的數據，預計到 2040 年，新的癌症病例將增加約 60%。癌症診斷的激增正在創造大量需要腫瘤營養產品和服務的潛在患者。癌症不是一種單一的疾病，而是一組具有不同類型和階段的疾病。每種類型的癌症和個別患者可能有獨特的營養需求。癌症患者群體的這種多樣性推動了針對特定要求量身定做的各種腫瘤營養解決方案的開發。癌症及其治療，包括化療、放射治療和手術，可能會帶來一系列營養挑戰。這些挑戰包括體重減輕、肌肉萎縮、營養不良、食慾不振和吞嚥困難。腫瘤營養在解決這些問題、提高患者的生活品質和整體健康方面發揮著至關重要的作用。充足的營養對於接受癌症治療的患者至關重要。營養支持可以幫助患者更好地耐受治療、保持體力並更快地從治療的副作用中恢復。反過來，這可以提高治療效果並減少併發症，最終使患者和醫療保健系統受益。癌症發生率的上升也導致人們更加重視癌症預防和存活。營養在癌症治療的兩個方面都發揮著關鍵作用。營養干涉措施被用來降低癌症發展的風險並改善癌症倖存者的長期健康，進一步擴大腫瘤營養產品和服務的市場。隨著人們越來越認知到每個癌症患者的營養需求都是獨特的，個人化營養計畫的趨勢日益明顯。醫療保健提供者正在根據患者的特定癌症類型、治療方案和整體健康狀況，為患者量身定做飲食建議。癌症沒有國界，影響全世界的人。隨著適當營養在癌症治療中的重要性得到越來越廣泛的認可，全球腫瘤營養市場正在擴大其範圍。它不僅限於已開發國家，也為發展中國家的患者提供服務，創造了更廣泛的市場足跡。

癌症患者的營養挑戰

全球腫瘤營養市場一直在經歷顯著成長，推動這項擴張的關鍵因素之一是對癌症患者面臨的營養挑戰的認知。癌症患者的旅程充滿了各種困難，保持適當的營養是他們護理的重要方面。癌症及其治療常常導致患者體重減輕和營養不良。此疾病引起的代謝變化會導致肌肉浪費和體重下降。營養不良會損害患者的整體健康並削弱他們耐受治療的能力。許多癌症患者會出現食慾不振，這種情況稱為厭食-惡病質症候群。對食物失去興趣可能是由於癌症本身和治療的副作用造成的。腫瘤營養產品和介入措施旨在透過提供更容易患者食用的營養豐富的解決方案來應對這項挑戰。某些癌症，特別是那些影響喉嚨或食道的癌症，可能會導致吞嚥困難，稱為吞嚥困難。這種情況使患者難以正常進餐。腫瘤營養包括流質飲食和管飼等解決方案，這些解決方案避免了傳統固體食物攝取的需求。適當的營養對於改善癌症患者的生活品質起著關鍵作用。營養不良和相關症狀會導致疲勞、虛弱和幸福感下降。腫瘤營養產品的配製就是為了解決這些問題，幫助患者在治療過程中感覺更好。營養支持對於幫助患者更好地耐受癌症治療的嚴酷（包括化療、放療和手術）至關重要。充足的營養可以確保患者的身體足夠強壯以承受治療的要求，從而提高治療效果。反過來，這可以帶來更好的治療結果。認知到癌症患者俱有獨特的營養需求，推動了個人化營養計劃的發展。醫療保健提供者會考慮癌症類型、治療方案和整體健康狀況等因素，為每位患者量身定做飲食建議。這種個人化方法是腫瘤營養市場成長的重要推手。腫瘤營養領域的特點是不斷創新。公司正在投資研發，以創造新的和改進的營養產品和服務，以滿足癌症患者不斷變化的需求。這些創新包括專門的口服補充劑、腸內和腸外營養解決方案以及專門針對癌症患者的飲食指南。

醫學研究的進展

全球腫瘤營養市場正在經歷顯著成長，醫學研究的進步在其擴張中發揮關鍵作用。隨著我們對癌症及其治療的理解不斷發展，我們對營養在癌症患者的健康和康復中發揮的關鍵作用的認知也在不斷發展。醫學研究加深了我們對癌症複雜性的理解。我們現在知道，癌症不是單一疾病，而是一組具有不同特徵的疾病。這種細緻入微的理解導致了量身定做的營養干涉措施的發展，旨在滿足不同癌症類型和階段的獨特需求。研究揭示了營養對癌症患者預後的深遠影響。越來越明顯的是，維持適當的營養對於控制癌症治療的副作用和改善患者的整體生活品質至關重要。醫學研究的進步揭示了營養如何減輕化療和放療等癌症治療的不良副作用。適當的營養可以幫助患者更好地耐受治療，減輕噁心、嘔吐和疲勞等症狀的嚴重程度。研究表明，營養在支持免疫系統方面發揮關鍵作用，而免疫系統對於對抗癌症至關重要。營養干涉可以增強免疫功能，有可能增強身體對抗癌細胞的能力，並降低治療期間出現併發症的風險。醫學研究強調了個人化醫療的重要性，這種方法已擴展到腫瘤營養學。研究結果促進了個人化營養計劃的製定，該計劃考慮了患者的特定癌症類型、治療方案和整體健康狀況等因素。這些個人化計劃可以更有效地解決每位患者獨特的營養挑戰。研究的進步推動了腫瘤營養產品開發的創新。市場上的公司正在投資研發，以創造改進的口服營養補充劑、腸內和腸外營養解決方案以及適合癌症患者需求的飲食指南。

市場創新

全球腫瘤營養市場正在經歷強勁成長，推動這項擴張的關鍵引擎之一是市場創新。為了為癌症患者獨特的營養需求提供有效的解決方案，公司正在突破研發界限，創造新穎的產品和服務。市場創新帶來了多樣化的腫瘤營養產品和服務組合。公司不斷開發新的和改進的解決方案，以滿足癌症患者不斷變化的需求。這包括各種口服營養補充劑、腸內和腸外營養選擇以及專為癌症患者量身定做的飲食指南。配方技術的創新帶來了更有效的腫瘤營養產品。這些產品旨在以易於消化的形式提供必需營養素。增強的配方可確保患者獲得必要的營養，即使他們因癌症及其治療而難以食用固體食物。市場創新推動了腫瘤學中個人化營養計畫的採用。醫療保健提供者認知到每個癌症患者的營養需求都是獨特的，客製化的飲食建議正在成為常態。這些量身定做的計劃考慮了患者的癌症類型、治療方案和整體健康狀況等因素。技術在市場創新中發揮重要作用。行動應用程式和數位平台被用來促進患者和醫療保健提供者之間的溝通。這些工具幫助患者追蹤他們的飲食攝取量，獲得個人化的營養指導，並監測他們的進展，從而提高對營養計劃的依從性。腫瘤營養市場的創新培育了以病人為中心的方法。本公司專注於患者教育和參與，確保患者充分了解營養在癌症治療過程中的重要性。以患者為中心的方法可提高治療依從性和整體福祉。公司正在大力投資研發以推動創新。這項投資推動了尖端營養產品和服務的創造。研究工作旨在了解癌症患者的營養需求並開發全面滿足這些需求的解決方案。

主要市場挑戰

監管障礙

腫瘤營養市場的主要挑戰之一是應對複雜的監管要求網路。不同國家對營養產品和膳食補充劑的生產和分銷有不同的規定。對於在全球範圍內營運的公司來說，滿足這些標準可能要求很高且耗時。

治療相關的副作用

化療和放療等癌症治療通常會導致使人衰弱的副作用，包括噁心、嘔吐和食慾不振。開發能夠有效解決這些副作用並維持患者營養狀況的營養解決方案是一項持續的挑戰。

患者依從性

確保患者遵守建議的營養計劃可能具有挑戰性。癌症患者可能會因味覺變化、食慾不振或吞嚥困難等因素而難以堅持。教育和激勵患者遵循規定的營養計劃是醫療保健提供者面臨的一項嚴峻挑戰。

成本限制

癌症患者通常面臨與治療相關的巨大經濟負擔，而專門的腫瘤營養產品的成本可能令人望而卻步。平衡有效營養支援的需求與成本限制是市場成長的一個具有挑戰性的面向。

主要市場趨勢

營養基因體學

營養基因組學是一個新興領域，探索個體的遺傳學與其飲食選擇之間的相互作用。在腫瘤營養市場中，這意味著使用遺傳資訊來制定專門針對每個患者的獨特需求和脆弱性的營養計劃。這一趨勢有可能徹底改變我們在癌症治療中的營養方式。

數位健康解決方案

數位健康解決方案的整合將徹底改變腫瘤營養學。行動應用程式、穿戴式裝置和遠距醫療平台將在監測和管理患者的營養需求方面發揮更重要的作用。這些工具將能夠即時追蹤飲食攝取量、症狀管理以及與醫療保健提供者的遠距諮詢。

功能性食品及營養保健品

人們對開發適合癌症患者需求的功能性食品和營養保健品越來越感興趣。這些產品超越了傳統的補充劑，透過添加生物活性化合物提供有針對性的營養支持，可能有助於控制與癌症相關的症狀和副作用。

永續和道德營養

永續性和道德考量在腫瘤營養市場中變得越來越突出。患者和醫療保健提供者對營養產品表現出興趣，這些產品不僅有效，而且以對環境負責且符合道德的方式生產。

細分市場洞察

癌症類型見解

根據癌症類型的類別，由於多種因素，預計肺癌部分將在整個研究期間出現成長。其中包括全球肺癌盛行率較高、肺癌患者營養補充劑使用量的增加以及人們日益認知到將營養補充劑涵蓋飲食的重要性。例如，根據《2022 年肺癌概況》報告，肺癌仍然是全球癌症相關死亡的主要原因。光是在美國，預計到2022 年將有236,740 人被診斷出患有肺癌，其中每16 人中就有1 人在其一生中被診斷出肺癌（每15 名男性中有1 名，每17 名女性中有1 名）。隨著癌症患者數量的不斷增加，人們越來越認知到營養在增強身體抵抗疾病的能力以及提供必要的力量和耐力來忍受治療副作用方面所發揮的重要作用。因此，預計在預測期內對腫瘤營養的需求將會增加。

最終使用者見解

由於幾個令人信服的原因，醫院藥房有望主導全球腫瘤營養市場。首先，醫院是癌症診斷和治療的主要中心，使其成為腫瘤護理連續體的核心。因此，他們在根據患者個別需求制定和管理專門的腫瘤營養解決方案方面發揮關鍵作用。其次，醫院藥局擁有管理癌症患者複雜的藥物和營養需求的基礎設施和專業知識，確保精確的劑量、安全性和合規性。第三，全球癌症病例發生率不斷上升，需要對腫瘤營養採取統一和規範的方法，而醫院藥房擁有獨特的能力來提供這種方法。此外，醫院藥局經常與腫瘤學家、營養師和醫療保健專業人員組成的多學科團隊合作，確保採用全面且以患者為中心的營養治療方法。這些因素，加上人們日益認知到營養在癌症護理中的關鍵作用，使醫院藥房成為不斷發展的全球腫瘤營養市場的主導參與者。

區域洞察

預計在整個預測期內，北美整個腫瘤營養市場將出現成長。這可以歸因於多種因素，包括癌症盛行率的增加和先進醫療基礎設施的存在等重要促進因素。例如，美國癌症協會 2022 年報告估計，美國同年新增癌症病例約 190 萬例。此外，政府機構的措施、新產品的推出以及與癌症營養補充品相關的合作也有助於市場擴張。例如，營養與飲食學會於2022年6月20日舉辦的「2022腫瘤營養研討會」討論了腫瘤營養的各個方面，包括研究、預防、治療、康復、安寧療護和臨終關懷等。

此外，加拿大癌症協會預測 2022 年加拿大將新增 233,900 例癌症病例。北美癌症病例發生率的上升預計將推動市場成長。此外，該地區還開展了大量認證計劃和宣傳活動，旨在教育癌症患者和醫療保健提供者了解腫瘤營養的重要性。其中一個例子是腫瘤營養研究所 (ONI)，該研究所提供現代、代謝、創新、綜合和基於結果的腫瘤營養治療的循證教育認證和培訓計劃。他們的旗艦產品 250 小時腫瘤營養諮詢 (ONC) 認證計劃是專為合格的營養、健康和醫療從業者設計的綜合培訓課程。因此，預計癌症病例數的增加將推動對腫瘤營養的需求，最終刺激市場成長。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖
    • 按癌症類型
    • 按營養
    • 按公式
    • 按配銷通路
    • 按最終用戶
    • 按地區

第 6 章：北美腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲腫瘤營養市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依癌症類型（肺癌、頭頸癌、胃癌和胃腸道癌、食道癌、肝癌、血癌、其他）
    • 依營養分類（腸內營養、腸外營養）
    • 依配方（標準配方、元素配方、專用配方）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按最終使用者（醫院、家庭護理、專科診所）
    • 按國家/地區
  • MEA：國家分析
    • 南非 腫瘤學 營養學
    • 沙烏地阿拉伯 腫瘤學 營養學
    • 阿拉伯聯合大公國 腫瘤學 營養學
    • 科威特 腫瘤學 營養學

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Abbott Laboratories Inc
    • Nestle SA
    • Fresenius Kabi AG
    • B Braun SE
    • Hormel Foods Corporation
    • Danone SA
    • MEIJI Holdings Co Ltd
    • Global Health Products, Inc.
    • Victus Inc
    • Mead Johnson & Co LLC

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 16384

The Global Oncology Nutrition Market, with a valuation of USD 2.14 billion in 2022, is poised for substantial growth in the forecast period, projecting an impressive Compound Annual Growth Rate (CAGR) of 8.41% through 2028. This global market pertains to the healthcare sector dedicated to offering specialized nutritional products and services to individuals dealing with cancer. Cancer, along with its treatments, can profoundly affect a patient's nutritional requirements and overall well-being. Oncology nutrition strives to meet these challenges by providing customized solutions that aid and sustain patients throughout their cancer journey.

Key Market Drivers

Rising Cancer Incidence

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.14 Billion
Market Size 2028USD 3.45 Billion
CAGR 2023-20288.41%
Fastest Growing SegmentEnteral Nutrition
Largest MarketNorth America

The global oncology nutrition market is witnessing a significant surge in demand, and one of the key drivers behind this growth is the alarming increase in cancer incidence worldwide. As cancer continues to affect more lives each year, the need for specialized nutritional support has never been greater. Cancer has reached epidemic proportions, with its incidence steadily rising across the globe. According to the World Cancer Research Fund, new cancer cases are projected to increase by approximately 60% by 2040. This surge in cancer diagnoses is creating a substantial pool of potential patients who require oncology nutrition products and services. Cancer is not a singular disease but rather a group of diseases with various types and stages. Each type of cancer and individual patient may have unique nutritional needs. This diversity within the cancer patient population has driven the development of a wide range of oncology nutrition solutions tailored to specific requirements. Cancer and its treatments, including chemotherapy, radiation therapy, and surgery, can lead to a host of nutritional challenges. These challenges include weight loss, muscle wasting, malnutrition, loss of appetite, and difficulty swallowing. Oncology nutrition plays a crucial role in addressing these issues, enhancing patients' quality of life and overall health. Adequate nutrition is vital for patients undergoing cancer treatment. Nutritional support can help patients better tolerate treatments, maintain their strength, and recover more swiftly from the side effects of therapy. This, in turn, can improve treatment efficacy and reduce complications, ultimately benefiting both patients and healthcare systems. The rising cancer incidence has also led to increased emphasis on cancer prevention and survivorship. Nutrition plays a pivotal role in both aspects of cancer care. Nutritional interventions are being used to reduce the risk of cancer development and improve the long-term health of cancer survivors, further expanding the market for oncology nutrition products and services. With the increasing recognition that each cancer patient's nutritional needs are unique, there has been a growing trend toward personalized nutrition plans. Healthcare providers are tailoring dietary recommendations to individual patients, taking into account their specific cancer type, treatment regimen, and overall health status. Cancer knows no boundaries, affecting people worldwide. As the importance of proper nutrition in cancer care becomes more widely acknowledged, the global oncology nutrition market is expanding its reach. It is not confined to developed countries but also serves patients in developing nations, creating a more extensive market footprint.

Nutritional Challenges in Cancer Patients

The global oncology nutrition market has been experiencing significant growth, and one of the pivotal factors propelling this expansion is the recognition of nutritional challenges faced by cancer patients. The journey of a cancer patient is fraught with various difficulties, and maintaining proper nutrition is a critical aspect of their care. Cancer and its treatments often lead to weight loss and malnutrition in patients. The metabolic changes caused by the disease can result in muscle waste and a decrease in body weight. Malnutrition can compromise the patient's overall health and weaken their ability to tolerate treatment. Many cancer patients experience a loss of appetite, a condition known as anorexia-cachexia syndrome. This loss of interest in food can result from both the cancer itself and the side effects of treatment. Oncology nutrition products and interventions are designed to address this challenge by providing nutrient-dense solutions that are easier for patients to consume. Certain cancers, particularly those affecting the throat or esophagus, can cause difficulty in swallowing, known as dysphagia. This condition makes it challenging for patients to eat regular meals. Oncology nutrition includes solutions like liquid diets and tube feeding, which circumvent the need for traditional solid food intake. Proper nutrition plays a pivotal role in improving the quality of life for cancer patients. Malnutrition and associated symptoms can lead to fatigue, weakness, and a diminished sense of well-being. Oncological nutrition products are formulated to combat these issues, helping patients feel better during their treatment journey. Nutritional support is vital to help patients better tolerate the rigors of cancer treatment, including chemotherapy, radiation therapy, and surgery. Adequate nutrition can enhance treatment efficacy by ensuring that the patient's body is strong enough to withstand the demands of therapy. This, in turn, can lead to better treatment outcomes. The recognition that cancer patients have unique nutritional needs has driven the development of personalized nutrition plans. Healthcare providers tailor dietary recommendations to each patient, taking into account factors such as cancer type, treatment regimen, and overall health status. This individualized approach is a significant driver of growth in the oncology nutrition market. The field of oncology nutrition is characterized by continuous innovation. Companies are investing in research and development to create new and improved nutritional products and services that cater to the evolving needs of cancer patients. These innovations include specialized oral supplements, enteral and parenteral nutrition solutions, and dietary guidelines specifically for cancer patients.

Advancements in Medical Research

The global oncology nutrition market is experiencing remarkable growth, with advancements in medical research playing a pivotal role in its expansion. As our understanding of cancer and its treatment continues to evolve, so too does our recognition of the critical role that nutrition plays in the well-being and recovery of cancer patients. Medical research has deepened our understanding of the complexities of cancer. We now know that cancer is not a single disease but a group of diseases with distinct characteristics. This nuanced understanding has led to the development of tailored nutritional interventions designed to address the unique needs of different cancer types and stages. Research has shed light on the profound impact of nutrition on cancer patients' outcomes. It has become increasingly clear that maintaining proper nutrition is essential for both managing the side effects of cancer treatment and improving patients' overall quality of life. Advancements in medical research have revealed how nutrition can mitigate the adverse side effects of cancer treatments such as chemotherapy and radiation therapy. Proper nutrition can help patients better tolerate treatment, reducing the severity of symptoms such as nausea, vomiting, and fatigue. Research has shown that nutrition plays a pivotal role in supporting the immune system, which is crucial in the fight against cancer. Nutritional interventions can boost immune function, potentially enhancing the body's ability to combat cancer cells and reduce the risk of complications during treatment. Medical research has emphasized the importance of personalized medicine, and this approach has extended to oncology nutrition. Research findings have led to the development of individualized nutrition plans that consider factors such as the patient's specific cancer type, treatment regimen, and overall health status. These personalized plans are more effective in addressing the unique nutritional challenges of each patient. Advancements in research have driven innovation in the development of oncology nutrition products. Companies in the market are investing in research and development to create improved oral nutritional supplements, enteral and parenteral nutrition solutions, and dietary guidelines tailored to cancer patients' needs.

Market Innovation

The global oncology nutrition market is experiencing robust growth, and one of the key engines propelling this expansion is market innovation. In the quest to provide effective solutions for cancer patients' unique nutritional needs, companies are pushing the boundaries of research and development, creating novel products and services. Market innovation has led to a diverse portfolio of oncology nutrition products and services. Companies are continually developing new and improved solutions that cater to the evolving needs of cancer patients. This includes a wide range of oral nutritional supplements, enteral and parenteral nutrition options, and dietary guidelines tailored specifically for cancer patients. Innovations in formulation techniques have resulted in more effective oncology nutrition products. These products are designed to provide essential nutrients in an easily digestible form. Enhanced formulations ensure that patients receive the necessary nutrients, even if they have difficulty eating solid foods due to cancer and its treatments. Market innovation has driven the adoption of personalized nutrition plans in oncology. Healthcare providers are recognizing that each cancer patient's nutritional needs are unique, and customized dietary recommendations are becoming the norm. These tailored plans consider factors such as the patient's cancer type, treatment regimen, and overall health status. Technology is playing a significant role in market innovation. Mobile apps and digital platforms are being used to facilitate communication between patients and healthcare providers. These tools help patients track their dietary intake, receive personalized nutrition guidance, and monitor their progress, improving adherence to nutrition plans. Innovation in the oncology nutrition market has fostered a patient-centered approach. Companies are focusing on patient education and engagement, ensuring that patients are well-informed about the importance of nutrition in their cancer journey. Patient-centered approaches enhance treatment compliance and overall well-being. Companies are investing heavily in research and development to drive innovation. This investment fuels the creation of cutting-edge nutritional products and services. Research efforts are directed toward understanding the nutritional needs of cancer patients and developing solutions that address these needs comprehensively.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges in the oncology nutrition market is navigating the complex web of regulatory requirements. Different countries have varying regulations regarding the production and distribution of nutritional products and dietary supplements. Meeting these standards can be demanding and time-consuming for companies operating on a global scale.

Treatment-Related Side Effects

Cancer treatments like chemotherapy and radiation therapy often lead to debilitating side effects, including nausea, vomiting, and loss of appetite. Developing nutrition solutions that can effectively address these side effects and maintain the patient's nutritional status is a continuous challenge.

Patient Compliance

Ensuring patient compliance with recommended nutrition plans can be challenging. Cancer patients may struggle with adherence due to factors like taste changes, lack of appetite, or difficulty in swallowing. Educating and motivating patients to follow their prescribed nutrition plans is a critical challenge for healthcare providers.

Cost Constraints

Cancer patients often face significant financial burdens related to their treatment, and the cost of specialized oncology nutrition products can be prohibitive. Balancing the need for effective nutrition support with cost constraints is a challenging aspect of market growth.

Key Market Trends

Nutrigenomics

Nutrigenomics is an emerging field that explores the interaction between an individual's genetics and their dietary choices. In the oncology nutrition market, this means using genetic information to create nutrition plans that are specifically designed to target the unique needs and vulnerabilities of each patient. This trend has the potential to revolutionize how we approach nutrition in cancer care.

Digital Health Solutions

The integration of digital health solutions is set to revolutionize oncology nutrition. Mobile apps, wearable devices, and telehealth platforms will play a more prominent role in monitoring and managing patients' nutritional needs. These tools will enable real-time tracking of dietary intake, symptom management, and remote consultations with healthcare providers.

Functional Foods and Nutraceuticals

There is growing interest in the development of functional foods and nutraceuticals tailored to the needs of cancer patients. These products go beyond traditional supplements, offering targeted nutritional support with added bioactive compounds that may help manage cancer-related symptoms and side effects.

Sustainable and Ethical Nutrition

Sustainability and ethical considerations are becoming more prominent in the oncology nutrition market. Patients and healthcare providers are showing interest in nutrition products that are not only effective but also produced in an environmentally responsible and ethically sourced manner.

Segmental Insights

Cancer Type Insights

Based on the category of Cancer Type, the lung cancer segment is expected to experience growth throughout the study period due to several factors. These include the global high prevalence of lung cancer, an increase in the use of nutritional supplements for lung cancer patients, and a growing awareness of the importance of incorporating nutritional supplements into one's diet. For example, according to the Lung Cancer Fact 2022 report, lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States alone, it was estimated that 236,740 individuals would be diagnosed with lung cancer in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer patients, there is a growing recognition of the vital role nutrition plays in bolstering the body's ability to combat disease and in providing the necessary strength and stamina to endure the side effects of treatment. As a result, the demand for oncology nutrition is expected to increase over the forecasted period.

Additionally, government initiatives are actively promoting proper nutrition for individuals undergoing cancer treatment and beyond. To support this objective, regulatory agencies are streamlining and revising regulations related to nutrition. As an example, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced bipartisan legislation known as the "Medical Nutrition Therapy Act." This legislation aims to expand Medicare Part B coverage to include medical nutrition therapy (MNT) services for a broader range of conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (such as celiac disease), cardiovascular disease, HIV/AIDS, and other conditions that result in unintentional weight loss. Such policy initiatives are likely to provide financial support to individuals and motivate them to be more proactive in incorporating nutritional supplements into their routines, thereby fostering growth in the market.

End User Insights

Hospital Pharmacy is poised to dominate the Global Oncology Nutrition Market for several compelling reasons. Firstly, hospitals serve as primary hubs for cancer diagnosis and treatment, making them central to the oncology care continuum. As a result, they play a pivotal role in prescribing and administering specialized oncology nutrition solutions tailored to individual patient needs. Secondly, hospital pharmacies have the infrastructure and expertise to manage complex pharmaceutical and nutritional requirements for cancer patients, ensuring precise dosing, safety, and compliance. Thirdly, the increasing incidence of cancer cases worldwide demands a consolidated and regulated approach to oncology nutrition, which hospital pharmacies are uniquely equipped to provide. Moreover, hospital pharmacies often collaborate with multidisciplinary teams of oncologists, dietitians, and healthcare professionals, ensuring a comprehensive and patient-centric approach to nutrition therapy. These factors, coupled with the growing recognition of the critical role of nutrition in cancer care, position hospital pharmacies as the dominant players in the evolving Global Oncology Nutrition Market.

Regional Insights

North America is anticipated to experience growth in the overall oncology nutrition market throughout the projected period. This can be attributed to various factors, including the increasing prevalence of cancer and the presence of advanced healthcare infrastructure, among other significant drivers. For instance, the American Cancer Society's 2022 report estimates approximately 1.9 million new cancer cases in the United States for the same year. Additionally, initiatives by government bodies, new product launches, and collaborations related to cancer nutrition supplements are contributing to market expansion. For example, the "2022 Oncology Nutrition Symposium" conducted by the Academy of Nutrition and Dietetics on June 20, 2022, addressed various aspects of oncology nutrition, encompassing research, prevention, treatment, recovery, palliative care, and hospice.

Furthermore, the Canadian Cancer Society forecasts 233,900 new cancer cases in Canada in 2022. The rising incidence of cancer cases across North America is expected to fuel market growth. Moreover, the region conducts numerous certification programs and awareness initiatives aimed at educating cancer patients and healthcare providers about the significance of oncology nutrition. One such example is the Oncology Nutrition Institute (ONI), which offers evidence-based educational certification and training programs in modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Their flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is a comprehensive training course designed for qualified nutrition, health, and medical practitioners. Consequently, the increasing number of cancer cases is projected to drive demand for oncology nutrition, ultimately stimulating market growth.

Key Market Players

  • Abbott Laboratories Inc
  • Nestle SA
  • Fresenius Kabi AG
  • B Braun SE
  • Hormel Foods Corporation
  • Danone SA
  • MEIJI Holdings Co Ltd
  • Global Health Products, Inc.
  • Victus Inc
  • Mead Johnson & Co LLC

Report Scope:

In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Nutrition Market, By Cancer Type:

  • Lung Cancer
  • Head and Neck Cancer
  • Stomach and Gastrointestinal Cancers
  • Esophageal Cancer
  • Liver Cancer
  • Blood Cancer
  • Others

Oncology Nutrition Market, By Nutrition:

  • Enteral Nutrition
  • Parenteral Nutrition

Oncology Nutrition Market, By Formula:

  • Standard Formula
  • Elemental Formula
  • Specialized Formula

Oncology Nutrition Market, By Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Oncology Nutrition Market, By End User:

  • Hospitals
  • Homecare
  • Specialty Clinics

Oncology Nutrition Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.

Available Customizations:

  • Global Oncology Nutrition market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oncology Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Cancer Type
    • 5.3.2. By Nutrition
    • 5.3.3. By Formula
    • 5.3.4. By Distribution Channel
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Oncology Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 6.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 6.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 6.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 6.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oncology Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cancer Type
        • 6.3.1.2.2. By Nutrition
        • 6.3.1.2.3. By Formula
        • 6.3.1.2.4. By Distribution Channel
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Oncology Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cancer Type
        • 6.3.2.2.2. By Nutrition
        • 6.3.2.2.3. By Formula
        • 6.3.2.2.4. By Distribution Channel
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Oncology Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cancer Type
        • 6.3.3.2.2. By Nutrition
        • 6.3.3.2.3. By Formula
        • 6.3.3.2.4. By Distribution Channel
        • 6.3.3.2.5. By End User

7. Europe Oncology Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 7.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 7.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 7.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 7.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oncology Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cancer Type
        • 7.3.1.2.2. By Nutrition
        • 7.3.1.2.3. By Formula
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Oncology Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cancer Type
        • 7.3.2.2.2. By Nutrition
        • 7.3.2.2.3. By Formula
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By End User
    • 7.3.3. France Oncology Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cancer Type
        • 7.3.3.2.2. By Nutrition
        • 7.3.3.2.3. By Formula
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Oncology Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cancer Type
        • 7.3.4.2.2. By Nutrition
        • 7.3.4.2.3. By Formula
        • 7.3.4.2.4. By Distribution Channel
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Oncology Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cancer Type
        • 7.3.5.2.2. By Nutrition
        • 7.3.5.2.3. By Formula
        • 7.3.5.2.4. By Distribution Channel
        • 7.3.5.2.5. By End User

8. Asia-Pacific Oncology Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 8.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 8.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 8.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 8.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oncology Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cancer Type
        • 8.3.1.2.2. By Nutrition
        • 8.3.1.2.3. By Formula
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By End User
    • 8.3.2. Japan Oncology Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cancer Type
        • 8.3.2.2.2. By Nutrition
        • 8.3.2.2.3. By Formula
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By End User
    • 8.3.3. India Oncology Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cancer Type
        • 8.3.3.2.2. By Nutrition
        • 8.3.3.2.3. By Formula
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By End User
    • 8.3.4. Australia Oncology Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cancer Type
        • 8.3.4.2.2. By Nutrition
        • 8.3.4.2.3. By Formula
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By End User
    • 8.3.5. South Korea Oncology Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cancer Type
        • 8.3.5.2.2. By Nutrition
        • 8.3.5.2.3. By Formula
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By End User

9. South America Oncology Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 9.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 9.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 9.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 9.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oncology Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cancer Type
        • 9.3.1.2.2. By Nutrition
        • 9.3.1.2.3. By Formula
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Oncology Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cancer Type
        • 9.3.2.2.2. By Nutrition
        • 9.3.2.2.3. By Formula
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Oncology Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cancer Type
        • 9.3.3.2.2. By Nutrition
        • 9.3.3.2.3. By Formula
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By End User

10. Middle East and Africa Oncology Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 10.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 10.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 10.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 10.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oncology Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cancer Type
        • 10.3.1.2.2. By Nutrition
        • 10.3.1.2.3. By Formula
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Oncology Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cancer Type
        • 10.3.2.2.2. By Nutrition
        • 10.3.2.2.3. By Formula
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Oncology Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cancer Type
        • 10.3.3.2.2. By Nutrition
        • 10.3.3.2.3. By Formula
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By End User
    • 10.3.4. Kuwait Oncology Nutrition Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Cancer Type
        • 10.3.4.2.2. By Nutrition
        • 10.3.4.2.3. By Formula
        • 10.3.4.2.4. By Distribution Channel
        • 10.3.4.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Abbott Laboratories Inc
    • 14.6.2. Nestle SA
    • 14.6.3. Fresenius Kabi AG
    • 14.6.4. B Braun SE
    • 14.6.5. Hormel Foods Corporation
    • 14.6.6. Danone SA
    • 14.6.7. MEIJI Holdings Co Ltd
    • 14.6.8. Global Health Products, Inc.
    • 14.6.9. Victus Inc
    • 14.6.10. Mead Johnson & Co LLC

15. Strategic Recommendations

16. About Us & Disclaimer